Oncogene-mediated signal transduction in transgenic mouse models of human breast cancer
Oncogene-mediated signal transduction in transgenic mouse models of human breast cancer
批准号:
333085
负责人:
Muller William J
金额:
$274.58万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-09-01 至 2022-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Breast cancer progression involves multiple events including the activation of dominant-acting oncogenes and the loss of specific tumor suppressor genes. These events can occur through well-established genetic mechanisms, such as mutation and chromosomal
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying the molecular and environmental factors involved in promoting escape from breast cancer dormancy.
-
批准号:488246
-
项目类别:Operating Grants
-
资助金额:$83.04万
-
财政年份:2023
-
负责人:Muller William J
-
依托单位:
Chi3L1 (YKL-40) plays a multifaceted role in modulating tumor immune microenvironment during breast cancer progression.
-
批准号:478513
-
项目类别:Operating Grants
-
资助金额:$93.07万
-
财政年份:2023
-
负责人:Muller William J
-
依托单位:
Identifying the molecular and environmental factors involved in promoting escape from breast cancer dormancy.
-
批准号:483129
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2023
-
负责人:Muller William J
-
依托单位:
Identification of Stat1 signaling pathway(s) involved in mediating tumor escape from immune surveillance.
-
批准号:490747
-
项目类别:Operating Grants
-
资助金额:$4.55万
-
财政年份:2023
-
负责人:Muller William J
-
依托单位:
The multifaceted role of c-Src tyrosine kinase in breast cancer progression.
-
批准号:468470
-
项目类别:Operating Grants
-
资助金额:$83.6万
-
财政年份:2022
-
负责人:Muller William J
-
依托单位:
Chi3L1 (YKL-40) plays a multifaceted role in modulating tumor immune microenvironment during breast cancer progression.
-
批准号:472379
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2022
-
负责人:Muller William J
-
依托单位:
Role of epigenetic modulation in breast cancer etiology and drug resistance.
-
批准号:368101
-
项目类别:Operating Grants
-
资助金额:$43.71万
-
财政年份:2017
-
负责人:Muller William J
-
依托单位:
The role of an alternative ErbB2 splice isoform in lung and breast cancer progression.
-
批准号:341907
-
项目类别:Operating Grants
-
资助金额:$59.59万
-
财政年份:2016
-
负责人:Muller William J
-
依托单位:
Development of a pre-clinical mouse model of Estrogen receptor alpha positive breast cancer to investigate the clinical efficacy of Selective Estrogen Receptor Modulators (SERMs)
-
批准号:341905
-
项目类别:Operating Grants
-
资助金额:$59.59万
-
财政年份:2016
-
负责人:Muller William J
-
依托单位:
Canada Research Chair Tier 1
-
批准号:341360
-
项目类别:
-
资助金额:$101.99万
-
财政年份:2015
-
负责人:Muller William J
-
依托单位:
Oncogene-mediated signal transduction in ErbB2 transgenic models of mammary tumour progression
-
批准号:280158
-
项目类别:Operating Grants
-
资助金额:$56.09万
-
财政年份:2013
-
负责人:Muller William J
-
依托单位:
Identification of PI-3K coupled signalling pathways involved in mammary tumour progression: Implication for resistance to targeted therapy.
-
批准号:291796
-
项目类别:Operating Grants
-
资助金额:$61.28万
-
财政年份:2013
-
负责人:Muller William J
-
依托单位:
Role of epigenetic modulation in breast cancer etiology and drug resistance
-
批准号:277365
-
项目类别:Operating Grants
-
资助金额:$54.64万
-
财政年份:2012
-
负责人:Muller William J
-
依托单位:
Integrin-mediated signal transduction in mammary tumourigenesis and metastasis
-
批准号:249551
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2011
-
负责人:Muller William J
-
依托单位:
The role of ErbB2-14-3-3 sigma signaling axis in cancer and development
-
批准号:199253
-
项目类别:Operating Grants
-
资助金额:$56.71万
-
财政年份:2010
-
负责人:Muller William J
-
依托单位:
The role of Epidermal Growth Factor Receptor Family in mammary tumorigenesis and metastasis
-
批准号:171470
-
项目类别:Operating Grants
-
资助金额:$56.48万
-
财政年份:2008
-
负责人:Muller William J
-
依托单位:
国内基金
海外基金
登录
查看更多内容
凉膈散抑制ErbB2介导的巨噬细胞重编程治疗急性呼吸窘迫综合征的作用机制研究
-
批准号:JCZRLH202600626
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ErbB2通过Nrf2/xCT介导氧化应激-糖代谢失衡在药物难治性颞叶癫痫中的作用机制与干预研究
-
批准号:2026JJ60091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖玲
-
依托单位:
转录因子SOX9通过LASP-1激活ErbB2/HIF-1α/SLC7A11信号轴抑制铁死亡和促进肺癌侵袭的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:石建光
-
依托单位:
ESM1通过ERBB2/FAK/SRC通路促进HSPB1转录抑制顺铂诱导卵巢癌铁死亡的机制研究
-
批准号:2025JJ50493
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李昱堃
-
依托单位:
AdipoRon 调控脂肪外泌体介导的 HGF/ERBB2/IRF6 抑制结
直肠癌的作用机制研究
-
批准号:2024JJ9552
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:艾琼嘉
-
依托单位:
ErbB2信号通路数学建模及其在乳腺癌耐药中应用研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:杨青
-
依托单位:
ErbB2第16号外显子可变剪接调控及其促进乳腺癌进展的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:张金瑞
-
依托单位:
DRG神经元ErbB2受体及其异源二聚体介导骨癌痛外周敏化及电针干预研究
-
批准号:82174510
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2021
-
负责人:梁宜
-
依托单位:
ERBB2/ERBB3功能异常诱导内皮细胞失稳态及其调控胆囊癌免疫逃逸的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:向冬喜
-
依托单位:
ERBB2突变激活PABPC3增强糖酵解在胆囊癌发生发展中的作用及机制研究
-
批准号:82072682
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:刘厚宝
-
依托单位: